# Atadasmed

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed September 19, 2026.

> Atadasmed provides an integrated telehealth platform for remote monitoring of medication-assisted treatment (MAT), patient retention, and medication adherence, initially specializing in opioid use disorder (OUD) to improve treatment outcomes and regulatory compliance.

- Business Profile: https://optimly.ai/brand/atadasmed
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://atadasmed.com/
- Logo: https://logo.clearbit.com/atadasmed.com
- Slug: atadasmed
- Brand Authority Index tier: Emerging
- Category: Remote Patient Monitoring (RPM) Platforms
- Last Analyzed: September 19, 2026

## Buyer Intent Signals
Problems: Opioid use disorder (OUD) treatment challenges | Low patient retention in treatment programs | Poor medication adherence | Complex regulatory compliance for controlled substances and specialty medications | Lack of remote monitoring solutions for MAT | Inefficient in-office pill counts and monitoring | Limited access to telehealth and virtual care for MAT | Lack of data and analytics for treatment outcomes and quality care metrics | Diversion control issues for controlled substances
Solutions: Telehealth medication monitoring | Patient engagement platforms | Medication adherence solutions | Regulatory compliance tools (e.g., pill count as a service) | Remote patient monitoring (RPM) for MAT | Virtual care access | Recovery assessment monitoring | Data-driven decision making for healthcare networks and payers | Automated evidence of treatment
Comparisons: Compare telehealth MAT platforms | Evaluate medication adherence solutions | Assess regulatory compliance software for controlled substances | Review patient retention improvement tools | ROI of telehealth monitoring for OUD | Effectiveness of remote recovery assessment